Summit Investment Advisors »

Amylyx Pharmaceuticals shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $74k 5.0k 14.72
2023-09-30 $92k 5.0k 18.31
2023-06-30 $87k 4.0k 21.57
2023-03-31 $118k 4.0k 29.34
2022-12-31 $153k 4.0k 37.90
2022-09-30 $77k 2.8k 27.86
2022-06-30 $14k 744 18.82
2022-03-31 $10k 744 13.44